tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
UBX is currently covered by 4 analysts
Unity Biotechnology's activity chart (see below) currently has 23 price targets and 34 ratings on display. The stock rating distribution of UBX is 90.91% BUY and 9.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 36.46% with an average time for these price targets to be met of 36.71 days.
Highest price target for UBX is $3, Lowest price target is $1.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 23-Apr-2025. First documented stock forecast 29-May-2018.
Currently out of the existing stock ratings of UBX, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4
$2.88 (257.14%)
$4
1 years 5 months 14 days ago
(23-Apr-2025)
0/6 (0%)
$3.01 (304.04%)
Buy
2 years 1 months 29 days ago
(08-Aug-2024)
0/4 (0%)
$5.95 (146.91%)
Buy
$2
2 years 10 months 21 days ago
(16-Nov-2023)
3/5 (60%)
$-1.11 (-35.69%)
66
Buy
$6
$4.88 (435.71%)
$5
3 years 4 months 11 days ago
(26-May-2023)
2/7 (28.57%)
$3.08 (105.48%)
80
Buy
$6
$4.88 (435.71%)
3 years 6 months 9 days ago
(28-Mar-2023)
2/3 (66.67%)
$4.25 (242.86%)
13
What is UBX (Unity Biotechnology) average time for price targets to be met?
Which analyst most recently updated their price target on UBX (Unity Biotechnology)?
Which analyst has the current lower performing score on UBX (Unity Biotechnology) with a proven track record?
Which analyst has the most public recommendations on UBX (Unity Biotechnology)?
Which analyst is the currently most bullish on UBX (Unity Biotechnology)?
Which analyst is the currently most reserved on UBX (Unity Biotechnology)?
